Related stories
CNO Financial raises 2026 operating EPS guidance to $5.05-$5.15
CNO Financial Group raised its 2026 operating EPS guidance to $5.05-$5.15.
M impact | EARNINGS | Nov 02, 2026, 07:53 PM UTC
Krystal Biotech Expects 2026 Adjusted Research and Administrative Costs
Krystal Biotech expects adjusted research and administrative expenses in 2026.
L impact | EARNINGS | Nov 02, 2026, 07:48 PM UTC
Krystal Biotech sets 2026 R&D and SG&A expense guidance at $155M-$165M
Krystal Biotech updated its 2026 non-GAAP R&D and SG&A expense guidance to $155 million-$165 million.
M impact | EARNINGS | Nov 02, 2026, 07:48 PM UTC
US Stocks Pare Most Gains
US stocks pared most of their earlier gains on Monday, with the S&P 500 hovering around the flatline and the Nasdaq slipping 0.4%, while the Dow Jones rose 350 points. Losses in en
H impact | EARNINGS | Nov 02, 2026, 07:33 PM UTC
Federal Signal Raises 2026 Adjusted EPS Outlook to $5.20-$5.32
M impact | EARNINGS | Nov 02, 2026, 07:04 PM UTC
Kentucky First Federal Bancorp Q3 Net Income Rises to $919K
For the quarter ended September 30, 2026, net income was $919K, or $0.11 diluted EPS, versus $344K and $0.04 a year earlier. Net interest income rose 25.5% to $3.1M.
M impact | EARNINGS | Nov 02, 2026, 06:56 PM UTC